Last updated: 08-03-2020

A Translational Approach to Addressing COVID-19


The process of developing new therapies and getting them to patients is long and difficult. During public health emergencies, science — and the process of turning observations into new therapies — must move faster than ever. That is where translational science comes in.

Translational science is focused on streamlining the process of moving (“translating”) lab findings into medical practice and treatments to improve health and well-being. NCATS is focused on advancing the science of translation.

NCATS is supporting research activities spanning the translational science spectrum to address the novel coronavirus 2019 (SARS-CoV-2) and the disease it causes (COVID-19). With the aim of accelerating translational research across all diseases, NCATS has developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues.

In addition, by using its networks to draw together experts with necessary and complementary skills, knowledge and experience, NCATS is enabling projects to cut through operational roadblocks.

Research Activities

Additional Resources


Open NCATS opportunities: NCATS has issued several notices of special interest that highlight the urgent need for research on SARS-CoV-2 and COVID-19. See all open NCATS funding opportunities.

Resources from the NIH Office of Extramural Research:

Updates from Grantees and Partners

NCATS-supported researchers are actively working on a variety of efforts to address the pandemic. See all grantee and partner updates.

NIH and CDC COVID-19 Resources


Image Caption: This scanning electron microscope image shows SARS-CoV-2 (round magenta objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the United States. (National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories)